This website uses cookies to enhance the user experience.
G

GENOFUEL AS926 839 608

Research
Limited company
c/o Tone Tønjum Operagata 69A 0194 OSLO, Norge

GENOFUEL AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO
Chairman of the board
Years since formation
3 years
since Mar 22, 2021
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
500
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2023
1,247,534
NOK
Annual total result 2023
-813,977
NOK
Total equity 2023
98,997
NOK
Last update: Oct 22, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member
60 %
indirectly
Chairman
20 %
indirectly

Others

NameRoleShares
B
BDO AS
Auditor-
H
HADELAND REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Board Member
60 %
indirectly
-
20 %
indirectly
Chairman
20 %
indirectly
Last update: Oct 22, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
G
GENOTEC HOLDING AS
Ordinary shares
500
100 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -26,645
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
1,247,534
839,382
26,250
Annual Total Result
-813,977
-570,523
-181,858
Total assets
2,467,001
1,256,470
507,754
Total liabilities
2,368,005
343,496
195,182
Total equity
98,997
912,974
312,572

P&L

Year202320222021
Total operating income
1,247,534
839,382
26,250
Total operating costs
2,065,064
1,409,843
208,108
Operating result
-817,529
-570,460
-181,858
Financial income/costs
3,552
-63
0
Profit before tax
-813,977
-570,523
-181,858
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-813,977
-570,523
-181,858

Balance overview

Year202320222021
Total fixed assets
482,353
0
0
Total current assets
1,984,648
1,256,470
507,754
Total assets
2,467,001
1,256,470
507,754
Short term debt
1,568,005
343,496
195,182
Long term debt
800,000
0
0
Total liabilities
2,368,005
343,496
195,182
Contributed capital
1,665,355
1,665,355
494,430
Retained earnings
-1,566,358
-752,381
-181,858
Total equity
98,997
912,974
312,572
Total equity and liabilities
2,467,001
1,256,470
507,754

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology